Left ventricular assist devices

An evolving state of the art

Jonathan D. Leff, Linda Shore-Lesserson

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Heart failure is a disease of increasing prevalence around the world. The treatment options for patients suffering from this ailment range from pharmacologic to surgical. Heart failure, however, continues to harbor a dismal prognosis despite conventional treatments. The high mortality rate among this patient population has spawned interest in alternative therapies. Mechanical circulatory support has emerged as a treatment option for patients with refractory heart failure. Over the past years a number of studies have highlighted the effectiveness of left ventricular assist devices (LVAD's) in improving patient's outcomes. The technologies that support these devices have evolved and provide new opportunities to manage patients suffering from this debilitating disease. Heart transplantation continues to generate the most reproducible survival benefit to patients with advanced heart failure, but is limited by a lack of donors. It is therefore the goal of mechanical assist therapy to improve patient survival and quality of life in heart failure in light of the limitations of heart transplantation. In this article we examine the evolving utility of LVAD's in the treatment of heart failure.

Original languageEnglish (US)
Pages (from-to)21-23
Number of pages3
JournalSeminars in Cardiothoracic and Vascular Anesthesia
Volume14
Issue number1
DOIs
StatePublished - Mar 2010

Fingerprint

Heart-Assist Devices
Heart Failure
Heart Transplantation
Survival
Therapeutics
Complementary Therapies
Treatment Failure
Quality of Life
Tissue Donors
Technology
Equipment and Supplies
Mortality
Population

Keywords

  • Axial flow devices
  • Congestive heart failure (CHF)
  • Left ventricular assist device (LVAD)
  • Magnetic levitation devices
  • Pulsatile flow devices

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Left ventricular assist devices : An evolving state of the art. / Leff, Jonathan D.; Shore-Lesserson, Linda.

In: Seminars in Cardiothoracic and Vascular Anesthesia, Vol. 14, No. 1, 03.2010, p. 21-23.

Research output: Contribution to journalArticle

@article{697a91a72920400fa6ceca39094ada36,
title = "Left ventricular assist devices: An evolving state of the art",
abstract = "Heart failure is a disease of increasing prevalence around the world. The treatment options for patients suffering from this ailment range from pharmacologic to surgical. Heart failure, however, continues to harbor a dismal prognosis despite conventional treatments. The high mortality rate among this patient population has spawned interest in alternative therapies. Mechanical circulatory support has emerged as a treatment option for patients with refractory heart failure. Over the past years a number of studies have highlighted the effectiveness of left ventricular assist devices (LVAD's) in improving patient's outcomes. The technologies that support these devices have evolved and provide new opportunities to manage patients suffering from this debilitating disease. Heart transplantation continues to generate the most reproducible survival benefit to patients with advanced heart failure, but is limited by a lack of donors. It is therefore the goal of mechanical assist therapy to improve patient survival and quality of life in heart failure in light of the limitations of heart transplantation. In this article we examine the evolving utility of LVAD's in the treatment of heart failure.",
keywords = "Axial flow devices, Congestive heart failure (CHF), Left ventricular assist device (LVAD), Magnetic levitation devices, Pulsatile flow devices",
author = "Leff, {Jonathan D.} and Linda Shore-Lesserson",
year = "2010",
month = "3",
doi = "10.1177/1089253210362270",
language = "English (US)",
volume = "14",
pages = "21--23",
journal = "Seminars in Cardiothoracic and Vascular Anesthesia",
issn = "1089-2532",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Left ventricular assist devices

T2 - An evolving state of the art

AU - Leff, Jonathan D.

AU - Shore-Lesserson, Linda

PY - 2010/3

Y1 - 2010/3

N2 - Heart failure is a disease of increasing prevalence around the world. The treatment options for patients suffering from this ailment range from pharmacologic to surgical. Heart failure, however, continues to harbor a dismal prognosis despite conventional treatments. The high mortality rate among this patient population has spawned interest in alternative therapies. Mechanical circulatory support has emerged as a treatment option for patients with refractory heart failure. Over the past years a number of studies have highlighted the effectiveness of left ventricular assist devices (LVAD's) in improving patient's outcomes. The technologies that support these devices have evolved and provide new opportunities to manage patients suffering from this debilitating disease. Heart transplantation continues to generate the most reproducible survival benefit to patients with advanced heart failure, but is limited by a lack of donors. It is therefore the goal of mechanical assist therapy to improve patient survival and quality of life in heart failure in light of the limitations of heart transplantation. In this article we examine the evolving utility of LVAD's in the treatment of heart failure.

AB - Heart failure is a disease of increasing prevalence around the world. The treatment options for patients suffering from this ailment range from pharmacologic to surgical. Heart failure, however, continues to harbor a dismal prognosis despite conventional treatments. The high mortality rate among this patient population has spawned interest in alternative therapies. Mechanical circulatory support has emerged as a treatment option for patients with refractory heart failure. Over the past years a number of studies have highlighted the effectiveness of left ventricular assist devices (LVAD's) in improving patient's outcomes. The technologies that support these devices have evolved and provide new opportunities to manage patients suffering from this debilitating disease. Heart transplantation continues to generate the most reproducible survival benefit to patients with advanced heart failure, but is limited by a lack of donors. It is therefore the goal of mechanical assist therapy to improve patient survival and quality of life in heart failure in light of the limitations of heart transplantation. In this article we examine the evolving utility of LVAD's in the treatment of heart failure.

KW - Axial flow devices

KW - Congestive heart failure (CHF)

KW - Left ventricular assist device (LVAD)

KW - Magnetic levitation devices

KW - Pulsatile flow devices

UR - http://www.scopus.com/inward/record.url?scp=77954916305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954916305&partnerID=8YFLogxK

U2 - 10.1177/1089253210362270

DO - 10.1177/1089253210362270

M3 - Article

VL - 14

SP - 21

EP - 23

JO - Seminars in Cardiothoracic and Vascular Anesthesia

JF - Seminars in Cardiothoracic and Vascular Anesthesia

SN - 1089-2532

IS - 1

ER -